Cargando…

Correction to: Managing Ibrutinib-Intolerant Patients With B-Cell Malignancies

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10243756/ https://www.ncbi.nlm.nih.gov/pubmed/36821849 http://dx.doi.org/10.1093/oncolo/oyad048

Ejemplares similares

Managing Ibrutinib-Intolerant Patients With B-Cell Malignancies
por: Muñoz, Javier, et al.
Publicado: (2023)

Ibrutinib for B cell malignancies
por: Novero, Aileen, et al.
Publicado: (2014)

P633: UPDATED SAFETY AND EFFICACY RESULTS OF ZANUBRUTINIB IN PATIENTS WITH B-CELL MALIGNANCIES WHO ARE INTOLERANT OF IBRUTINIB AND/OR ACALABRUTINIB
por: Shadman, Mazyar, et al.
Publicado: (2023)

Targets for Ibrutinib Beyond B Cell Malignancies
por: Berglöf, A., et al.
Publicado: (2015)

Correction: Utility of Corrected QT Interval in Orthostatic Intolerance
Publicado: (2015)

Ibrutinib repurposing: from B-cell malignancies to solid tumors
por: Massó-Vallés, Daniel, et al.
Publicado: (2016)

Correction: The combination effect of homoharringtonine and ibrutinib on FLT3-ITD mutant acute myeloid leukemia
por: Li, Xia, et al.
Publicado: (2019)

Correction: Vitamin C and folate status in hereditary fructose intolerance
por: Cano, Ainara, et al.
Publicado: (2023)

Correction: Genic Intolerance to Functional Variation and the Interpretation of Personal Genomes
por: Petrovski, Slavé, et al.
Publicado: (2013)

Correction: Intestinal Ralstonia pickettii augments glucose intolerance in obesity
Publicado: (2018)

Correction to: Role of Bruton’s tyrosine kinase in B cells and malignancies
por: Pal Singh, Simar, et al.
Publicado: (2019)

Correction to: Treatment of hydroxyurea-resistant/intolerant polycythemia vera: a discussion of best practices
por: Kuykendall, Andrew T.
Publicado: (2023)

Food Intolerance and Food Aversion
Publicado: (1984)

Correction: Protective Effects of Myricetin on Acute Hypoxia-Induced Exercise Intolerance and Mitochondrial Impairments in Rats
por: Zou, Dan, et al.
Publicado: (2015)

Correction: Orion: Detecting regions of the human non-coding genome that are intolerant to variation using population genetics
por: Gussow, Ayal B., et al.
Publicado: (2018)

PB1890: ZANUBRUTINIB IN ACALABRUTINIB-INTOLERANT PATIENTS (PTS) WITH B-CELL MALIGNANCIES
por: Shadman, M., et al.
Publicado: (2022)

Correction to: Bruton Tyrosine Kinase Inhibitors in B-Cell Malignancies: Their Use and Differential Features
por: Shirley, Matt
Publicado: (2021)

Observational study of lenalidomide in patients with mantle cell lymphoma who relapsed/progressed after or were refractory/intolerant to ibrutinib (MCL-004)
por: Wang, Michael, et al.
Publicado: (2017)

Correction: Combining MAD and CPAP as an effective strategy for treating patients with severe sleep apnea intolerant to high-pressure PAP and unresponsive to MAD
por: Liu, Hsiang-Wen, et al.
Publicado: (2018)

Clinical Trials of the BTK Inhibitors Ibrutinib and Acalabrutinib in Human Diseases Beyond B Cell Malignancies
por: Zhu, Sining, et al.
Publicado: (2021)

Correction: Mice Lacking the p43 Mitochondrial T3 Receptor Become Glucose Intolerant and Insulin Resistant during Aging
por: Bertrand, Christelle, et al.
Publicado: (2014)

Correction: Incidence and contributing factors of glucose intolerance in Saudi postpartum women: Sub-group analysis from RAHMA study
por: Wahabi, Hayfaa, et al.
Publicado: (2019)

Correction to: A systematic review of mitochondrial abnormalities in myalgic encephalomyelitis/chronic fatigue syndrome/systemic exertion intolerance disease
por: Holden, Sean, et al.
Publicado: (2020)

P644: IBRUTINIB DOSE MODIFICATIONS FOR MANAGEMENT OF CARDIAC ADVERSE EVENTS IN PATIENTS WITH B-CELL MALIGNANCIES: POOLED ANALYSIS OF 10 CLINICAL TRIALS
por: Stephens, Deborah, et al.
Publicado: (2023)

Author Correction: COVID-19-related school closing aggravate obesity and glucose intolerance in pediatric patients with obesity
por: Kim, Eun Sil, et al.
Publicado: (2021)

Disseminated Cryptococcosis With Brain Involvement in Patients With Chronic Lymphoid Malignancies on Ibrutinib
por: Messina, Julia A., et al.
Publicado: (2017)

Ibrutinib dose modifications in the management of CLL
por: Hardy-Abeloos, Camille, et al.
Publicado: (2020)

Correction to: Intolerance of Uncertainty, Looming Cognitive Style, and Avoidant Coping as Predictors of Anxiety and Depression During COVID-19: a Longitudinal Study
por: Carnahan, Nicolette D., et al.
Publicado: (2021)

Inhibition of effector B cells by ibrutinib in systemic sclerosis
por: Einhaus, Jakob, et al.
Publicado: (2020)

Author Correction: ERV1 Overexpression in Myeloid Cells Protects against High Fat Diet Induced Obesity and Glucose Intolerance
por: Sima, Corneliu, et al.
Publicado: (2018)

Ibrutinib in Gynecological Malignancies and Breast Cancer: A Systematic Review
por: Metzler, Julian Matthias, et al.
Publicado: (2020)

288. Hepatitis B Virus Reactivation in Patients with Hematologic Malignancies after Anticancer Therapy Which Included Ibrutinib
por: Malek, Alexandre, et al.
Publicado: (2019)

Risk of Bleeding Associated With Ibrutinib in Patients With B-Cell Malignancies: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
por: Wang, Jinjin, et al.
Publicado: (2020)

Correction to: Malignant epithelioid hemangioendothelioma of the ear
Publicado: (2022)

How to Manage Atrial Fibrillation Secondary to Ibrutinib
por: Essa, Hani, et al.
Publicado: (2021)

Correction to: Management of duodenal stump fistula after gastrectomy for malignant disease: a systematic review of the literature
por: Zizzo, Maurizio, et al.
Publicado: (2019)

Correction to: Second International Consensus Conference on lesions of uncertain malignant potential in the breast (B3 lesions)
por: Rageth, Christoph J., et al.
Publicado: (2019)

Ibrutinib in B-cell lymphoma: single fighter might be enough?
por: Xue, Chao, et al.
Publicado: (2020)

Ibrutinib Resistance Mechanisms and Treatment Strategies for B-Cell Lymphomas
por: George, Bhawana, et al.
Publicado: (2020)

Correction to: Microsatellite instability in noncolorectal and nonendometrial malignancies in patients with Lynch syndrome
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_229rdr955bcnamrmontac2oe50